These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

677 related articles for article (PubMed ID: 31664453)

  • 1. Schizophrenia-An Overview.
    McCutcheon RA; Reis Marques T; Howes OD
    JAMA Psychiatry; 2020 Feb; 77(2):201-210. PubMed ID: 31664453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A rare and not very studied disorder: childhood-onset schizophrenia. A case report].
    Bailly D; de Chouly de Lenclave MB
    Encephale; 2004; 30(6):540-7. PubMed ID: 15738856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schizophrenia: from phenomenology to neurobiology.
    Wong AH; Van Tol HH
    Neurosci Biobehav Rev; 2003 May; 27(3):269-306. PubMed ID: 12788337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cognition, schizophrenia and the effect of antipsychotics].
    Stip E
    Encephale; 2006; 32(3 Pt 1):341-50. PubMed ID: 16840928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frontal D2/3 Receptor Availability in Schizophrenia Patients Before and After Their First Antipsychotic Treatment: Relation to Cognitive Functions and Psychopathology.
    Nørbak-Emig H; Ebdrup BH; Fagerlund B; Svarer C; Rasmussen H; Friberg L; Allerup PN; Rostrup E; Pinborg LH; Glenthøj BY
    Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26819282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative symptoms of schizophrenia: clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment.
    Millan MJ; Fone K; Steckler T; Horan WP
    Eur Neuropsychopharmacol; 2014 May; 24(5):645-92. PubMed ID: 24820238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating the Neurodevelopmental and Dopamine Hypotheses of Schizophrenia and the Role of Cortical Excitation-Inhibition Balance.
    Howes OD; Shatalina E
    Biol Psychiatry; 2022 Sep; 92(6):501-513. PubMed ID: 36008036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schizophrenia: diverse approaches to a complex disease.
    Sawa A; Snyder SH
    Science; 2002 Apr; 296(5568):692-5. PubMed ID: 11976442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcranial Direct Current Stimulation for the Treatment of Refractory Symptoms of Schizophrenia. Current Evidence and Future Directions.
    Mondino M; Brunelin J; Palm U; Brunoni AR; Poulet E; Fecteau S
    Curr Pharm Des; 2015; 21(23):3373-83. PubMed ID: 26088110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDE Inhibitors for the Treatment of Schizophrenia.
    Snyder GL; Vanover KE
    Adv Neurobiol; 2017; 17():385-409. PubMed ID: 28956340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schizophrenia: revisited.
    Provencher HL; Fournier JP; Dupuis N
    J Psychiatr Ment Health Nurs; 1997 Aug; 4(4):275-85. PubMed ID: 9362830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neurodevelopmental hypothesis in schizophrenia].
    Gourion D; Gourevitch R; Leprovost JB; Olié H lôo JP; Krebs MO
    Encephale; 2004; 30(2):109-18. PubMed ID: 15107713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents.
    Miyamoto S; Miyake N; Jarskog LF; Fleischhacker WW; Lieberman JA
    Mol Psychiatry; 2012 Dec; 17(12):1206-27. PubMed ID: 22584864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schizophrenia: a review of current research and thinking.
    Coffey M
    J Clin Nurs; 1998 Nov; 7(6):489-98. PubMed ID: 10222943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schizophrenia: from neurochemistry to circuits, symptoms and treatments.
    Howes OD; Bukala BR; Beck K
    Nat Rev Neurol; 2024 Jan; 20(1):22-35. PubMed ID: 38110704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
    Swainston Harrison T; Perry CM
    Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcortical Dopamine and Cognition in Schizophrenia: Looking Beyond Psychosis in Preclinical Models.
    Conn KA; Burne THJ; Kesby JP
    Front Neurosci; 2020; 14():542. PubMed ID: 32655348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.